Pulmonary and mediastinal paragangliomas: rare endothoracic malignancies with challenging diagnosis and treatment.

Background Pulmonary and mediastinal paragangliomas are rare tumors that may have neuroendocrine activity or be non-functional, incidental, in asymptomatic patients, or causing mass effect symptoms. Although being low-grade tumors, they can display an aggressive behaviour, developing local infiltration and distant metastases. We report our experience with three endothoracic paragangliomas and a Literature review, to point out diagnostic difficulties and problems related to surgical treatment. Methods From 2009 to 2017, we treated 3 patients with histological diagnosis of paraganglioma: 2 pulmonary, 1 mediastinal. No one presented catecholamine-secreting syndromes; pulmonary cases were asymptomatic, while the mediastinal one had aspecific cough and dyspnea. Imaging diagnosis was based on chest computerized tomography (CT) and magnetic resonance imaging (MRI) scan. No patient had preoperative histological diagnosis. Intraoperative pathological examination was suggestive for malignancy: in pulmonary cases, wedge resection and lobectomy were performed; the middle mediastinal mass was completely removed after challenging dissection, isolation and section of numerous vascular pedicles. Results Postoperative course was uneventful in all cases. No patient received adjuvant treatments. At a median follow-up of 47 months (range, 6-102 months), two patients are alive, without local or distant recurrence; one patient died 6 months after surgery, due to disease progression. Conclusions Endothoracic paragangliomas, rare and often asymptomatic tumors, are of difficult diagnosis and should be considered malignant tumors, due to the potential aggressive behaviour of cases with high mitotic index and the frequent possibility of recurrence and metastases. Surgical resection is the treatment of choice and careful intraoperative manipulation is recommended, due to the high vascularity of these tumors, to prevent complications. After complete excision, long-term prognosis is generally good. However, even after surgical removal, a close, periodical and life-long follow-up is mandatory.

[1]  Á. Muñoz-Herrera,et al.  Mediastinal paraganglioma fed by the left circumflex artery. , 2016, Interactive Cardiovascular and Thoracic Surgery.

[2]  S. Baba,et al.  Mediastinal paraganglioma , 2020, Japanese Journal of Radiology.

[3]  G. Fiorentino,et al.  Primary paraganglioma of the lung: a case report , 2015, Journal of Medical Case Reports.

[4]  Liming Xu,et al.  Duodenal gangliocytic paraganglioma: report of two cases and review of literature. , 2015, International journal of clinical and experimental pathology.

[5]  A. Bharat,et al.  Rare Middle Mediastinal Paraganglioma Mimicking Metastatic Neuroendocrine Tumor. , 2015, The Annals of thoracic surgery.

[6]  M. Ergin,et al.  A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib , 2014, Cancer research and treatment : official journal of Korean Cancer Association.

[7]  Si-Wook Kim,et al.  Mediastinal Paraganglioma: Complete Resection Using Video-Assisted Thoracoscopic Surgery , 2014, The Korean journal of thoracic and cardiovascular surgery.

[8]  S. Toyooka,et al.  Asymptomatic but functional paraganglioma of the posterior mediastinum. , 2014, The Annals of thoracic surgery.

[9]  Yun Lin,et al.  Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature , 2013, OncoTargets and therapy.

[10]  E. Krishnan,et al.  Mediastinal paraganglioma between the great vessels in an 81-year-old woman. , 2013, Texas Heart Institute journal.

[11]  J. Lippert,et al.  Anterior mediastinal paraganglioma: A case for preoperative embolization , 2012, World Journal of Surgical Oncology.

[12]  I. Mader,et al.  Head and neck paragangliomas: clinical and molecular genetic classification , 2012, Clinics.

[13]  Lei Feng,et al.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  C. Parisinos,et al.  Mediastinal paraganglioma: time to panic? , 2011, BMJ Case Reports.

[15]  H. Lehnert,et al.  Metastatic paraganglioma. , 2010, Seminars in oncology.

[16]  O. Wald,et al.  Paraganglioma of the mediastinum: challenges in diagnosis and surgical management , 2010, Journal of cardiothoracic surgery.

[17]  D. Huglo,et al.  Local-regional recurrence of sporadic or syndromic abdominal extra-adrenal paraganglioma: incidence, characteristics, and outcome. , 2009, Surgery.

[18]  J. Carney,et al.  Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. , 2009, The Journal of clinical endocrinology and metabolism.

[19]  Yih-Leong Chang,et al.  Non-functional paraganglioma of the posterior mediastinum. , 2009, Interactive cardiovascular and thoracic surgery.

[20]  J. Carney,et al.  The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney–Stratakis syndrome): molecular genetics and clinical implications , 2009, Journal of internal medicine.

[21]  O. Ismail,et al.  Posterior mediastinal paragangliomas: A report of three patients with peculiar tumours , 2009, Respirology.

[22]  M. Abel,et al.  Mediastinal paragangliomas: the mayo clinic experience. , 2008, The Annals of thoracic surgery.

[23]  M. Roh,et al.  Pulmonary Paraganglioma Manifesting as an Endobronchial Mass , 2008, Korean journal of radiology.

[24]  E. Campo,et al.  Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. , 2007, The Journal of clinical endocrinology and metabolism.

[25]  S. Aranki,et al.  Functional paraganglioma of the middle mediastinum. , 2007, The Annals of thoracic surgery.

[26]  D. Torigian,et al.  Cross-sectional imaging of paragangliomas of the aortic body and other thoracic branchiomeric paraganglia. , 2007, AJR. American journal of roentgenology.

[27]  S. Takamoto,et al.  Successful perioperative management of a middle mediastinal paraganglioma. , 2006, Journal of Thoracic and Cardiovascular Surgery.

[28]  W. Young,et al.  Paragangliomas , 2006, Annals of the New York Academy of Sciences.

[29]  R. Younes,et al.  Primary pulmonary paraganglioma: case report and literature review. , 2006, Clinics.

[30]  H. Takeyama,et al.  An extremely large solitary primary paraganglioma of the lung: Report of a case , 1999, Surgery today (Print).

[31]  C. F. Andrade,et al.  Nonfunctioning paraganglioma of the aortopulmonary window. , 2003, The Annals of thoracic surgery.

[32]  J. Strauchen Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[33]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[34]  M. Walther,et al.  Biochemical diagnosis of pheochromocytoma: which test is best? , 2002, JAMA.

[35]  W. Rubinstein,et al.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.

[36]  W. Young,et al.  Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. , 2001, The Journal of clinical endocrinology and metabolism.

[37]  A. Duranceau,et al.  Preoperative embolization in the management of a mediastinal paraganglioma. , 2001, The Annals of thoracic surgery.

[38]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[39]  C. Eng,et al.  Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.

[40]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[41]  B. Nelems,et al.  Anterior and middle mediastinum paraganglioma: complete resection is the treatment of choice. , 1994, The Annals of thoracic surgery.

[42]  J. Fernández-Llamazares,et al.  Functioning metastases of a nonfunctioning paraganglioma , 1988, Journal of surgical oncology.

[43]  J. Olson,et al.  Mediastinal paragangliomas (Aortic body tumor). A report of four cases and a review of the literature , 1978, Cancer.